La Rosa de los Vientos
383 - Ep. 373 - AbbVie M&A, FDA reversals, a CAR T first
00:00
00:00
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.
For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Épisodes
383-
Ep. 373 - AbbVie M&A, FDA reversals, a CAR T first
Écouté
382-
Ep. 372 - Biotech IPOs, Biosecure Act, cachexia pipeline
Écouté
381-
Ep. 371 - Moving faster at the academia-industry interface
Écouté
380-
Ep. 370 - Calmer waters for FDA; Servier, Lilly deals
Écouté
379-
